AMP Partners
AMP Partners
AMP is a multi-sector partnership. AMP partners share expertise and resources to enable the best-informed contributions to science from all participants.
Government
- FDA
 - NIH
 - European Medicines Agency
 
Industry
- AbbVie
 - Amgen
 - Bayer US
 - Biogen Inc.
 - Boehringer Ingelheim
 - Bristol Myers Squibb
 - Celgene Corporation
 - Cytokinetics, Inc.
 - Danaher Corporation
 - Eisai Inc.
 - Eli Lilly and Company
 - Elipida
 - EMD Serono
 - Forge
 - Gates Ventures
 - GlaxoSmithKline plc
 - Ionis Pharmaceuticals, Inc.
 - Janssen Research & Development, LLC
 - Merck Sharp & Dohme Corp.
 - Mitsubishi Tanabe Pharma America, Inc.
 - Novo Nordisk
 - Novartis AG
 - Otsuka Pharmaceutical Development & Commercialization, Inc.
 - Ovid Therapeutics Inc.
 - Pfizer Inc.
 - QurAlis
 - REGENXBIO Inc.
 - Sanofi
 - Spark Therapeutics
 - Takeda Pharmaceutical Company Limited
 - Taysha Gene Therapies
 - Thermo Fisher Scientific
 - UCB
 - Ultragenyx Pharmaceutical
 - Ultromics
 - Verily
 - Vistera
 
Non-Profit
- Alliance for Regenerative Medicine (ARM)
 - Aligning Science Across Parkinson’s (ASAP) Initiative
 - ALS Association
 - ALS Therapy Developement Institute
 - ALS United
 - Alzheimer’s Association®
 - American Heart Association®
 - American Diabetes Association
 - American Psychiatric Association Foundation
 - American Society of Gene & Cell Therapy
 - American Society of Echocardiography (ASE)
 - Answer ALS
 - Autoimmune Foundation
 - California Institute for Regenerative Medicine
 - Critical Path Institute
 - CureDuchenne
 - Foundation Fighting Blindness
 - Foundation for the NIH
 - Gates Ventures
 - Genetic Alliance
 - GENETHON
 - JDRF International
 - Lupus Foundation of America
 - Lupus Research Alliance
 - Michael J. Fox Foundation for Parkinson’s Research
 - National Alliance on Mental Illness
 - National Organization for Rare Disorders (NORD)
 - National Psoriasis Foundation
 - One Mind
 - PhRMA
 - Rett Syndrome Research Trust
 - Rheumatology Research Foundation
 - RTW Charitable Foundation
 - Sjögren’s Foundation
 - Target ALS
 - The Arthritis Foundation, Inc.
 - The Association for Frontotemporal Degeneration
 - The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
 - Schizophrenia & Psychosis Action Alliance
 - Wellcome
 
This page last reviewed on